查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1835373

靜脈系統接取設備市場（按設備類型、技術、應用和最終用戶）—2025-2032 年全球預測

Intravenous System Access Devices Market by Device Type, Technology, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，靜脈系統接取設備市場將成長至 81.2 億美元，複合年成長率為 6.70%。

主要市場統計數據
基準年2024年 48.3億美元
預計2025年 51.3億美元
預測年份：2032年 81.2億美元
複合年成長率（%） 6.70%

背景介紹，解釋影響血管內通路設備採用和創新的臨床、操作和監管促進因素

靜脈系統通路設備是現代臨床照護的基石，可為各種治療和診斷提供持續的血管通路。本分析涵蓋的設備涵蓋中樞和周邊血管通路解決方案，旨在滿足從短期復甦到長期輸液和家庭治療等各種臨床需求。隨著臨床方案日益複雜，醫療保健專業人員和採購團隊越來越需要兼具安全性、易用性和適應不斷變化的照護路徑的設備。

本報告首先將這些設備置於更廣泛的臨床和營運環境中。報告檢驗了由於人口結構變化、慢性病盛行率上升、門診治療範圍擴大以及複雜治療方法轉向門診和家庭治療，設備使用模式如何改變。監管審查和感染預防重點仍然是產品設計和採購選擇的核心促進因素。因此，製造商專注於材料科學、整合安全性和以工作流程為導向的創新，以減少併發症並簡化臨床程序。

引言部分從背景介紹到策略重點，闡明了報告的範圍和分析架構。它概述了所審查的設備類別和技術分類，描述了所考慮的臨床應用，並摘要了用於評估供應商、臨床應用障礙以及影響產品生命週期的監管動態的調查方法。

分析臨床、技術和供應鏈融合趨勢，重塑醫療環境中的設備設計採用途徑和籌資策略

由於臨床、技術和經濟因素的融合，靜脈通路器材領域已進入轉型重組期。材料和整合安全技術的進步正從漸進式改進轉向平台級增強，這些改進優先考慮封閉式系統完整性、連接器標準化和無針通路，以降低感染風險。這項技術轉變與日益重視以使用者為中心的設計相吻合，這降低了操作複雜性，並支援在非急診醫院環境中採用。

同時，臨床實踐模式也在不斷發展。門診輸液治療的擴展和居家醫療項目的加速推進，為中線和周邊插入器械帶來了新的需求訊號，這些器械需要兼顧治療時間長度、安全插入和維護便利性。監管機構正在加大對上市後監管和器械可追溯性的關注，鼓勵製造商投資於標籤、唯一器械標識和品質體系，以便在必要時快速採取糾正措施。同時，供應鏈彈性已成為一項策略重點，相關人員正在尋求多元化供應商，並為關鍵製造流程提供資源，以降低中斷風險。

總的來說，這些轉變要求公司協調研發、製造和商業模式，以支援跨環境護理、整合安全性和連接性，並提供適合臨床醫生工作流程和以患者為中心的護理途徑的系統。

重點評估不斷變化的關稅政策如何影響醫療設備採購決策、製造足跡和策略性供應鏈調整

影響醫療設備供應鏈的貿易政策和關稅動態，正在加劇對籌資策略和成本結構的審查。關稅的徵收或調整會對原料採購、零件進口和成品定價產生連鎖反應，迫使製造商重新評估供應商合約和物流安排。對於靜脈通路器械而言，這類器械通常依賴全球採購的聚合物零件、精密製造和滅菌服務，關稅負擔的增加促使製造獎勵重新評估地理佈局和供應商關係。

因此，相關人員已參與情境規劃，以了解累積成本負擔、關稅實施時機以及緩解措施，例如本地化生產、篩選合格的替代供應商以及重新設計產品以減少對關稅敏感型投入的淨利率。過渡期影響包括與供應商重新談判、逐步增加庫存，以及注重供應鏈可視性，以防止利潤率下降，同時維持對臨床醫生和患者的產品供應。

重要的是，應對主導壓力的營運響應並非憑空而來。法規合規性、品質監督和上市時間限制決定了供應鏈轉移的可行性和節奏。因此，許多公司優先考慮一種混合模式，將關鍵零件的近岸外包與商品化投入的多元化全球採購相結合，同時採用合約和營運對沖來保持連續性並管理財務風險。

全面的細分整合將設備架構、臨床應用和最終用戶環境連結起來，以確定產品的適用性和商業化優先級

細緻的細分框架清楚地闡明了臨床需求、技術和護理環境的交匯點，從而決定了設備的選擇和創新重點。根據設備類型，市場分為中心靜脈通路和周邊靜脈通路。中心靜脈通路包括植入式裝置、非隧道式導管、周邊置入的中央靜脈導管、隧道式中央靜脈導管和帶套囊的中央靜脈導管，每種導管均針對不同的治療時間和風險狀況進行了最佳化。周邊通路包括中線靜脈導管和周邊靜脈導管，用於短期至中期治療，並擴大用於門診和家庭環境中，在這些環境中，易於插入和維護至關重要。

從技術角度來看，設備可分為封閉式、整合式和開放式系統。封閉式系統強調透過封閉路徑預防感染；整合式系統將多種功能元素（例如安全性和存取控制）整合到統一的平台中；開放式系統則優先考慮模組化和相容性。這些技術差異決定了採購選擇，取決於臨床優先順序、互通性要求和員工培訓考慮。

應用維度涵蓋臨床用例（例如輸血、診斷檢測、藥物管理以及液體和營養支援）如何影響設備規格。每種應用對流量、相容性和停留時間的要求各不相同，從而為產品選擇和通訊協定提供參考。最後，終端使用者細分區分門診手術中心、居家醫療、長期照護機構以及醫院和診所，並認知到設備功能和包裝必須與每種護理環境的功能和工作流程一致。這些細分視角為評估產品適用性、開發優先順序和商業化策略提供了實用的架構。

區域分析比較了美洲、歐洲、中東和非洲以及亞太地區的採購動態、監管重點和臨床採用模式

區域動態對各市場的臨床應用、監管途徑及商業策略有重大影響。在美洲，醫療保健提供者需要管理複雜的私人和公共付款人組合、大量的手術以及強大的門診護理基礎設施，這推動了對性能可靠、工作流程簡化且符合嚴格安全標準的設備的需求。該地區的買家通常優先考慮那些具有明確臨床價值和營運效率、並擁有強大的報銷途徑和成熟分銷網路的產品。

在歐洲、中東和非洲，監管機構優先考慮統一安全標準，而由於採購策略和預算限制，醫療保健系統差異巨大。該地區的相關人員擴大採用能夠降低併發症發生率和整體醫療保健成本的技術，同時兼顧可負擔性和合規性。此外，私營部門的成長和公共衛生領域的投資正在創造基於品質和上市後支援的產品差異化機會。

在亞太地區，醫療基礎設施的快速現代化、門診和居家醫療服務覆蓋範圍的擴大以及國內製造業的雄心壯志正在塑造一個充滿活力的競爭格局。尋求進入該地區的製造商優先考慮可擴展的生產模式、監管參與以及適應當地的臨床實踐和採購機制。綜合起來，這些區域模式要求製造商根據每個地區的臨床重點和營運現狀，客製化其上市方案、監管策略和供應鏈佈局。

評估競爭性創新路徑和策略夥伴關係將決定市場領導地位和長期產品可行性

靜脈通路器械市場的競爭動態體現在差異化產品組合、策略夥伴關係以及技術和製造方面的定向投資。領先公司通常會在核心產品線與相關創新之間取得平衡，例如整合固定系統、抗菌材料以及旨在提升相容性並降低操作複雜性的連接器標準化概念。為了滿足臨床醫生的偏好和報銷壓力，各公司也在擴展服務，以支援培訓、應用和遠端監控，從而降低併發症率並展示實際應用效果。

合併和策略聯盟仍然是獲取材料科學、滅菌技術和封閉式系統工程領域能力的常見途徑。同時，規模較小的專業化公司通常專注於利基臨床問題或平台創新，而大型製造商則會選擇性地收購或授權這些技術。由於從研發到規模化的轉變需要強大的品質系統和監管敏銳度，許多公司正在投資本地製造和監管能力，以加快核准和本地市場准入。

供應鏈的韌性和成本管理也將決定競爭定位。擁有多元化、品質有保證的供應基礎並投資於裁員的公司，將在市場波動期間享有更大的靈活性。最終，市場領導地位將屬於那些將臨床證據生成、以用戶為中心的設計、可擴展的生產以及與多種環境下醫療服務趨勢相符的商業模式相結合的公司。

為製造商和醫療系統提供一系列切實可行的策略行動，以提高創新供應鏈的彈性，並將證據產生與商業性執行結合起來，以實現有意義的採用

產業領導者應推行協調一致的議程，將產品創新與營運韌性和已證實的臨床價值結合。首先，優先考慮能夠降低感染風險和操作複雜性的設計，透過整合封閉式系統功能和鎖定機制，同時確保與常見連接器和輸液標準的兼容性。其次，制定平衡成本效益和供應鏈韌性的生產策略。實現零件採購多元化，選擇合格的區域生產合作夥伴，並建立緊急庫存，以在供應中斷期間保持臨床供應的連續性。

第三，投資於產生證據，證明其在醫院、門診手術中心和居家醫療環境中的實際應用效果。過渡性應用通常依賴案例研究和試驗計畫，這些研究和項目能夠證明併發症減少、手術時間縮短或整體醫療成本降低。第四，加強監管和上市後監測能力，以加快核准並快速回應安全訊號。第五，培育商業模式，包括臨床醫生培訓、實施支援和服務提供，以降低非醫院環境中的應用門檻。

透過協調實施這些優先事項，公司可以改善產品與市場的契合度，最大限度地降低與貿易和供應中斷相關的營運風險，並基於臨床影響和營運可靠性創造永續的競爭優勢。

混合方法調查方法，將主要臨床醫生研究與次要監管和技術審查以及供應鏈映射相結合。

支撐本分析的研究將結構化的一手資料研究與全面的二手資料研究以及系統級供應鏈圖譜相結合，以確保研究的嚴謹性和適用性。一手資料研究包括對急診和門診病人臨床醫生、採購主管、監管專家和設備工程師的訪談，旨在獲取關於設備性能、採用障礙和工作流程整合的實證見解。這些討論促成了對產品屬性和採用促進因素進行定性優先排序，這些屬性和促進因素在實際應用中至關重要。

二次研究整合了監管指南、臨床實踐建議、同行評審文獻和公開的技術規範，以檢驗產品分類並了解安全性和性能預期。供應鏈分析繪製了聚合物導管、連接器和滅菌服務的典型組件流程圖，突顯了融合點和潛在瓶頸。調查方法包括交叉檢驗一手資料和二手資料、對訪談結果進行主題編碼以及對技術和監管趨勢進行三角測量。

為確保可信度，調查團隊記錄了各種假設，考慮了替代政策和貿易轉變情景，並對營運影響進行了敏感性檢驗。最終得出了一套切實可行、以行動為導向的綜合方案，將臨床重點與產品特性以及製造商和醫療保健系統的戰略需求緊密結合。

綜合結果和簡明結論強調了臨床重點、監管準備和供應鏈彈性是血管通路設備策略成功的支柱

最後，血管通路器械對於現代醫療服務依然至關重要，其發展也反映了向門診護理、感染預防和彈性供應鏈的廣泛轉變。如今，臨床需求優先考慮安全、易用且適用於所有醫療環境的器械，而製造商則面臨著對循證醫學、法規遵從性和業務連續性的日益成長的期望。因此，將產品創新與實際臨床工作流程和採購現實相結合是成功的關鍵。

展望未來，投資於整合安全能力、區域製造靈活性和可靠上市後證據的相關人員將最有能力滿足臨床醫生的需求，並應對複雜的監管和貿易環境。此外，夥伴關係將抓住最持久的機會。

整體而言，這個市場提出了重要的策略選擇：透過專注於臨床影響、供應鏈彈性和嚴謹的證據生成，公司可以創造永續的競爭優勢，同時為患者照護帶來有意義的改善。

目錄

第1章 引言

第2章分析方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 擴大採用無針靜脈輸液系統，以減少針刺傷並簡化工作流程
  • 開發具有即時數據分析功能的整合輸液泵，實現更智慧的靜脈輸液治療管理
  • 增加抗菌塗層靜脈導管的使用，以降低加加護病房的感染風險
  • 人們對封閉式靜脈導管系統的興趣日益濃厚，以最大限度地減少腫瘤治療期間的污染
  • 為加護治療病患提供血流動力學監測的擴展靜脈通路裝置
  • 隨著永續性措施的推進，對環保型一次性靜脈輸液組件的需求激增
  • 整合支援 RFID 的 IV 管連接器，以增強可追溯性和病患安全通訊協定。
  • 採用超音波導引周邊靜脈通路套件提高首次嘗試成功率
  • 不斷發展的數位健康平台，整合靜脈輸液設備的使用和電子健康記錄

第6章：美國關稅的累積影響（2025年）

第7章：人工智慧（AI）的累積影響（2025年）

8. 靜脈系統接取設備市場（依設備類型）

  • 中心靜脈通路
    • 植入式裝置
    • 非隧道導管
    • 周邊置入中央靜脈導管
    • 隧道式附袖套中央靜脈導管
  • 周邊靜脈通路
    • 中線導管
    • PIV導管

9. 靜脈系統接取設備市場（依技術）

  • 封閉系統
  • 整合系統
  • 開放系統

第 10 章靜脈系統接取設備市場（依應用）

  • 輸血
  • 診斷測試
  • 藥物管理
  • 補水和營養

第 11 章靜脈系統接取設備市場（依最終用戶）

  • 門診手術中心
  • 居家醫療、長期照護機構
  • 醫院和診所

12. 靜脈系統接取設備市場（依地區）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第 13 章靜脈系統接取設備市場（依類別）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

14. 靜脈系統接取設備市場（依國家）

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章競爭格局

  • 市佔率分析（2024年）
  • FPNV定位矩陣（2024年）
  • 競爭分析
    • Access Vascular, Inc.
    • Angiplast Private Limited
    • Argon Medical Devices, Inc.
    • B. Braun SE
    • Baxter International Inc.
    • Becton, Dickinson and Company
    • Delta Med SpA
    • Disposafe Health and Life Care Ltd.
    • FAS United Medical Company
    • Fresenius SE & Co. KGaA
    • Hangzhou Fushan Medical Appliances Co., LTD.
    • Harsoria Healthcare Pvt Ltd
    • IV Access Technology, Inc.
    • ICU Medical, Inc. by Otsuka Holdings Co. Ltd.
    • Kimal PLC
    • Medilivescare Manufacturing Private Limited
    • Medivac Surgical Pvt. Ltd.
    • Medtronic PLC
    • Narang Medical Limited
    • Ningbo GreatCare Trading Co., Ltd.
    • Nipro Corporation
    • Poly Medicure Limited
    • Teleflex Incorporated
    • Terumo Corporation
    • Vygon SAS
Product Code: MRR-43127F7279F2

The Intravenous System Access Devices Market is projected to grow by USD 8.12 billion at a CAGR of 6.70% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 4.83 billion
Estimated Year [2025] USD 5.13 billion
Forecast Year [2032] USD 8.12 billion
CAGR (%) 6.70%

A contextual introduction that explains the clinical, operational, and regulatory drivers shaping adoption and innovation in vascular access devices

Intravenous system access devices constitute a foundational element of contemporary clinical care, enabling sustained vascular access for a broad spectrum of therapies and diagnostics. The devices covered in this analysis span central and peripheral vascular access solutions designed to meet diverse clinical requirements, from short-term resuscitation to long-term infusion and home-based therapies. As clinical protocols have grown more sophisticated, practitioners and procurement teams increasingly demand devices that combine safety features, ease of use, and compatibility with evolving care pathways.

This report opens by situating these devices within the broader clinical and operational context. It examines how demographic shifts, rising chronic disease prevalence, expanded outpatient care, and the migration of complex therapies to ambulatory and home settings have altered device utilization patterns. Regulatory scrutiny and infection prevention priorities remain central drivers of product design and procurement choices. Consequently, manufacturers have concentrated on materials science, integrated safety, and workflow-oriented innovations to reduce complications and streamline clinical procedures.

Transitioning from context to strategic priorities, the introduction clarifies the report's scope and analytical framework. It outlines the device categories and technological classifications under review, explains the clinical applications considered, and summarizes the methodological approach used to evaluate suppliers, clinical adoption barriers, and regulatory dynamics that shape product lifecycles.

An analysis of converging clinical, technological, and supply chain trends that are reshaping device design adoption pathways and procurement strategies across care settings

The intravenous access device landscape has entered a period of transformative realignment driven by converging clinical, technological, and economic forces. Advances in materials and integrated safety technologies have moved beyond incremental improvements toward platform-level enhancements that prioritize closed-system integrity, connector standardization, and needleless access to reduce infection risk. These technological shifts coincide with a growing emphasis on user-centered design that lowers procedure complexity and supports adoption across settings beyond the acute hospital.

Meanwhile, clinical practice patterns are evolving. The expansion of outpatient infusion therapies and the acceleration of home healthcare programs have created new demand signals for midline and peripherally inserted devices that balance duration of therapy with insertion safety and ease of maintenance. Regulatory agencies have increased focus on post-market surveillance and device traceability, prompting manufacturers to invest in labeling, unique device identification, and quality systems that facilitate rapid corrective action when needed. In parallel, supply chain resilience has become a strategic priority; stakeholders are diversifying suppliers and reshoring critical manufacturing steps to mitigate disruption risk.

Taken together, these shifts demand that companies align R&D, manufacturing, and commercial models to support cross-setting care, integrate safety and connectivity features, and deliver systems that fit both clinician workflows and patient-centered care pathways.

A focused evaluation of how evolving tariff policies are influencing sourcing decisions manufacturing footprints and strategic supply chain adjustments for medical devices

Trade policy and tariff dynamics affecting medical device supply chains have intensified scrutiny of sourcing strategies and cost structures. When tariff measures are applied or adjusted, they transmit through raw material procurement, component imports, and finished device pricing, prompting manufacturers to reassess vendor contracts and logistics arrangements. For intravenous access devices, which often rely on polymer components, precision manufacturing, and sterilization services sourced globally, any incremental tariff burden increases the incentive to re-evaluate geographic footprints and supplier relationships.

Consequently, stakeholders have undertaken scenario planning to understand cumulative cost exposure, timing of tariff implementation, and mitigation pathways such as localizing production, qualifying alternative suppliers, or redesigning products to reduce dependence on tariff-sensitive inputs. Transitional impacts include renegotiated supplier contracts, phased inventory adjustments, and greater emphasis on supply chain visibility to prevent margin erosion while preserving product availability for clinicians and patients.

Importantly, the operational response to tariff-driven pressure does not occur in isolation. Regulatory compliance, quality oversight, and time-to-market constraints shape the feasibility and pace of supply chain shifts. As a result, many firms prioritize a hybrid approach that combines nearshoring for critical components with diversified global sourcing for commoditized inputs, while employing contractual and operational hedges to maintain continuity and manage financial exposure.

A comprehensive segmentation synthesis linking device architectures technologies clinical applications and end-user contexts to illuminate product fit and commercialization priorities

A nuanced segmentation framework clarifies where clinical need, technology, and care setting intersect to shape device selection and innovation priorities. By device type, markets separate into central intravenous access and peripheral intravenous access categories. Central options encompass implantable devices, non-tunneled catheters, peripherally inserted central catheters, and tunneled and cuffed central catheters, each optimized for differing duration of therapy and risk profiles. Peripheral access includes midline catheters and peripheral intravenous catheters, which address short- to intermediate-duration therapies and are increasingly used in ambulatory and home settings where ease of insertion and maintenance are critical.

From a technology standpoint, devices cluster into closed systems, integrated systems, and open systems. Closed systems emphasize infection prevention through sealed pathways, integrated systems combine multiple functional elements such as securement and access management into unified platforms, and open systems prioritize modularity and interchangeability. These technological distinctions drive procurement choices depending on clinical priorities, interoperability requirements, and staff training considerations.

The application dimension captures how clinical use cases influence device specification, covering blood transfusion, diagnostic testing, drug administration, and fluid and nutritional support. Each application poses different flow, compatibility, and dwell-time demands that inform product selection and procedural protocols. Finally, end-user segmentation distinguishes ambulatory surgical centers, homecare settings and long-term care facilities, and hospitals and clinics, recognizing that device features and packaging must align with the capabilities and workflows of each care environment. Together, these segmentation lenses provide a practical structure for evaluating product fit, development priorities, and commercialization strategies.

A regional analysis that contrasts procurement dynamics regulatory priorities and clinical adoption patterns across the Americas Europe Middle East Africa and Asia-Pacific

Regional dynamics materially influence clinical adoption, regulatory pathways, and commercial strategies across the market. In the Americas, healthcare providers navigate a complex mix of private and public payers, high procedural volumes, and robust outpatient care infrastructure, driving demand for devices that deliver reliable performance, streamlined workflows, and compliance with stringent safety standards. In this region, purchasers often prioritize products that demonstrate clear clinical value and operational efficiencies, supported by strong reimbursement pathways and established distribution networks.

In Europe, the Middle East and Africa, regulators emphasize harmonized safety standards, while health systems vary widely in procurement sophistication and budgetary constraints. Stakeholders in this region balance affordability with compliance, and they increasingly adopt technologies that demonstrate reduced complication rates and lower total cost of care. In addition, private-sector growth and public health investments create opportunities for product differentiation based on quality and post-market support.

Across Asia-Pacific, rapid modernization of healthcare infrastructure, expanding access to outpatient and homecare services, and domestic manufacturing ambitions shape a dynamic competitive landscape. Manufacturers pursuing this region prioritize scalable production models, regulatory engagement, and adaptations for local clinical practices and procurement mechanisms. Collectively, these regional patterns require manufacturers to customize go-to-market approaches, regulatory strategies, and supply chain footprints to align with each area's clinical priorities and operational realities.

An assessment of competitive positioning innovation pathways and strategic partnerships that determine market leadership and long-term product viability

Competitive dynamics in the intravenous access device market manifest through differentiated portfolios, strategic partnerships, and targeted investments in technology and manufacturing. Leading organizations typically balance core product lines with adjacent innovations such as integrated securement systems, antimicrobial materials, and connector standardization initiatives that facilitate compatibility and reduce procedural complexity. In response to clinician preferences and reimbursement pressures, companies have also extended services that support training, adoption, and remote monitoring to reduce complication rates and demonstrate real-world performance.

Mergers and strategic alliances remain a common pathway for acquiring capability in materials science, sterilization technologies, and closed-system engineering. Concurrently, smaller specialized firms often focus on niche clinical problems or platform innovations that larger manufacturers selectively acquire or license. Transitioning from R&D to scale requires robust quality systems and regulatory acumen, so many companies invest in regional manufacturing and regulatory affairs capabilities to accelerate approvals and local market access.

Supply chain resilience and cost control also shape competitive positioning. Firms that secure diversified, quality-assured supply bases and invest in redundancy enjoy greater flexibility during disruption. Ultimately, market leadership accrues to organizations that combine clinical evidence generation, user-centered design, scalable manufacturing, and commercial models that align with care delivery trends across multiple settings.

A pragmatic set of strategic actions for manufacturers and health systems to align innovation supply chain resilience evidence generation and commercial execution for meaningful adoption

Industry leaders should pursue a coordinated agenda that aligns product innovation with operational resilience and clinical value demonstration. First, prioritize designs that reduce infection risk and procedural complexity by integrating closed-system features and securement mechanisms, while ensuring compatibility with prevailing connector and infusion standards. Second, deploy manufacturing strategies that balance cost efficiency with supply chain resilience; diversify component sourcing, qualify regional production partners, and develop contingency inventories to sustain clinical supply continuity during disruptions.

Third, invest in evidence generation that demonstrates real-world outcomes across hospitals, ambulatory surgical centers, and homecare environments. Transitional adoption often depends on case studies and pilot programs that document reduced complications, shortened procedure times, or lower total care costs. Fourth, strengthen regulatory and post-market surveillance capabilities to accelerate approvals and to respond rapidly to safety signals. Fifth, cultivate commercial models that include clinician training, onboarding support, and service offerings that lower the barrier to adoption in non-hospital settings.

By executing on these priorities in a coordinated manner, companies can improve product-market fit, minimize operational risks associated with trade or supply interruptions, and create durable competitive advantages grounded in clinical impact and operational reliability.

A transparent description of the mixed-methods research approach that integrates primary clinician insights secondary regulatory and technical review and supply chain mapping

The research underpinning this analysis combines structured primary engagements, comprehensive secondary review, and systems-level supply chain mapping to ensure rigor and applicability. Primary research included interviews with clinicians across acute and outpatient settings, procurement leaders, regulatory specialists, and device engineers to capture experiential insights on device performance, adoption barriers, and workflow integration. These discussions informed qualitative prioritization of product attributes and adoption levers that matter in real-world settings.

Secondary research synthesized regulatory guidance, clinical practice recommendations, peer-reviewed literature, and publicly available technical specifications to validate product classifications and to understand safety and performance expectations. Supply chain analysis mapped typical component flows for polymer-based catheters, connectors, and sterilization services, highlighting points of concentration and potential bottlenecks. The methodological approach employed cross-validation between primary and secondary sources, thematic coding of interview responses, and triangulation of technological trends with regulatory trajectories.

To ensure reliability, the research team documented assumptions, reviewed alternative scenarios for policy and trade shifts, and conducted sensitivity checks on operational implications. The result is a defensible, action-oriented synthesis that connects clinical priorities to product attributes and strategic imperatives for manufacturers and health systems.

A concise concluding synthesis that emphasizes clinical priorities regulatory readiness and supply chain resilience as the pillars of strategic success in vascular access devices

In closing, intravenous access devices remain a critical enabler of modern care delivery, and their evolution reflects broader shifts toward outpatient therapies, infection prevention, and resilient supply chains. Clinical demand now prioritizes devices that combine safety, ease of use, and cross-setting applicability, while manufacturers face intensifying expectations for evidence, regulatory compliance, and operational continuity. Consequently, success depends on aligning product innovation with real-world clinical workflows and procurement realities.

Looking ahead, stakeholders who invest in integrated safety features, regional manufacturing flexibility, and robust post-market evidence will be best positioned to meet clinician needs and to navigate regulatory and trade complexities. Moreover, partnerships that accelerate training, streamline adoption, and provide real-world performance data will create tangible differentiation in procurement conversations. As healthcare delivery models continue to decentralize, the firms that translate clinical insight into practical, reliable device systems will capture the most durable opportunities.

Overall, the market presents significant strategic choices; by emphasizing clinical impact, supply chain resilience, and disciplined evidence generation, organizations can deliver meaningful improvements in patient care while building sustainable competitive advantage.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Increasing adoption of needle-free IV access systems to reduce needlestick injury and streamline workflows
  • 5.2. Development of integrated infusion pumps with real-time data analytics for smarter IV therapy management
  • 5.3. Rise in antimicrobial-coated IV catheters to mitigate infection risks in critical care settings
  • 5.4. Growing preference for closed IV catheter systems to minimize contamination during oncology treatments
  • 5.5. Introduction of wearable IV infusion devices for ambulatory chemotherapy and patient mobility support
  • 5.6. Expansion of IV access devices with hemodynamic monitoring capabilities for intensive care patients
  • 5.7. Surge in demand for eco-friendly disposable IV components following sustainability initiatives
  • 5.8. Integration of RFID-enabled IV tubing connectors to enhance traceability and patient safety protocols
  • 5.9. Adoption of ultrasound-guided peripheral IV access kits to improve first-attempt success rates
  • 5.10. Evolution of digital health platforms integrating IV device usage with electronic health records

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Intravenous System Access Devices Market, by Device Type

  • 8.1. Central Intravenous Access
    • 8.1.1. Implantable Devices
    • 8.1.2. Non-tunneled Catheters
    • 8.1.3. Peripherally Inserted Central Catheter
    • 8.1.4. Tunneled & Cuffed Central Catheter
  • 8.2. Peripheral Intravenous Access
    • 8.2.1. Midline Catheter
    • 8.2.2. PIV Catheter

9. Intravenous System Access Devices Market, by Technology

  • 9.1. Closed System
  • 9.2. Integrated System
  • 9.3. Open System

10. Intravenous System Access Devices Market, by Application

  • 10.1. Blood Transfusion
  • 10.2. Diagnostic Testing
  • 10.3. Drug Administration
  • 10.4. Fluid & Nutritional Support

11. Intravenous System Access Devices Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Homecare Settings & Long-term Care Facilities
  • 11.3. Hospitals & Clinics

12. Intravenous System Access Devices Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Intravenous System Access Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Intravenous System Access Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Access Vascular, Inc.
    • 15.3.2. Angiplast Private Limited
    • 15.3.3. Argon Medical Devices, Inc.
    • 15.3.4. B. Braun SE
    • 15.3.5. Baxter International Inc.
    • 15.3.6. Becton, Dickinson and Company
    • 15.3.7. Delta Med S.p.A.
    • 15.3.8. Disposafe Health and Life Care Ltd.
    • 15.3.9. FAS United Medical Company
    • 15.3.10. Fresenius SE & Co. KGaA
    • 15.3.11. Hangzhou Fushan Medical Appliances Co., LTD.
    • 15.3.12. Harsoria Healthcare Pvt Ltd
    • 15.3.13. I-V Access Technology, Inc.
    • 15.3.14. ICU Medical, Inc. by Otsuka Holdings Co. Ltd.
    • 15.3.15. Kimal PLC
    • 15.3.16. Medilivescare Manufacturing Private Limited
    • 15.3.17. Medivac Surgical Pvt. Ltd.
    • 15.3.18. Medtronic PLC
    • 15.3.19. Narang Medical Limited
    • 15.3.20. Ningbo GreatCare Trading Co., Ltd.
    • 15.3.21. Nipro Corporation
    • 15.3.22. Poly Medicure Limited
    • 15.3.23. Teleflex Incorporated
    • 15.3.24. Terumo Corporation
    • 15.3.25. Vygon SAS

LIST OF FIGURES

  • FIGURE 1. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. INTRAVENOUS SYSTEM ACCESS DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY NON-TUNNELED CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY NON-TUNNELED CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY NON-TUNNELED CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY NON-TUNNELED CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY NON-TUNNELED CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY NON-TUNNELED CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TUNNELED & CUFFED CENTRAL CATHETER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TUNNELED & CUFFED CENTRAL CATHETER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TUNNELED & CUFFED CENTRAL CATHETER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TUNNELED & CUFFED CENTRAL CATHETER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TUNNELED & CUFFED CENTRAL CATHETER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TUNNELED & CUFFED CENTRAL CATHETER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY MIDLINE CATHETER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY MIDLINE CATHETER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY MIDLINE CATHETER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY MIDLINE CATHETER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY MIDLINE CATHETER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY MIDLINE CATHETER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PIV CATHETER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PIV CATHETER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PIV CATHETER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PIV CATHETER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PIV CATHETER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PIV CATHETER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CLOSED SYSTEM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CLOSED SYSTEM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CLOSED SYSTEM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CLOSED SYSTEM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CLOSED SYSTEM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CLOSED SYSTEM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY INTEGRATED SYSTEM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY INTEGRATED SYSTEM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY INTEGRATED SYSTEM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY INTEGRATED SYSTEM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY INTEGRATED SYSTEM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY INTEGRATED SYSTEM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY OPEN SYSTEM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY OPEN SYSTEM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY OPEN SYSTEM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY OPEN SYSTEM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY OPEN SYSTEM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY OPEN SYSTEM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY BLOOD TRANSFUSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY BLOOD TRANSFUSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY BLOOD TRANSFUSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY BLOOD TRANSFUSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY BLOOD TRANSFUSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY BLOOD TRANSFUSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DIAGNOSTIC TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DIAGNOSTIC TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DIAGNOSTIC TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DIAGNOSTIC TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DIAGNOSTIC TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DIAGNOSTIC TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DRUG ADMINISTRATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DRUG ADMINISTRATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DRUG ADMINISTRATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DRUG ADMINISTRATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DRUG ADMINISTRATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DRUG ADMINISTRATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY FLUID & NUTRITIONAL SUPPORT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY FLUID & NUTRITIONAL SUPPORT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY FLUID & NUTRITIONAL SUPPORT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY FLUID & NUTRITIONAL SUPPORT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY FLUID & NUTRITIONAL SUPPORT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY FLUID & NUTRITIONAL SUPPORT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY HOMECARE SETTINGS & LONG-TERM CARE FACILITIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY HOMECARE SETTINGS & LONG-TERM CARE FACILITIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY HOMECARE SETTINGS & LONG-TERM CARE FACILITIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY HOMECARE SETTINGS & LONG-TERM CARE FACILITIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY HOMECARE SETTINGS & LONG-TERM CARE FACILITIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY HOMECARE SETTINGS & LONG-TERM CARE FACILITIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. AMERICAS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 128. AMERICAS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 129. AMERICAS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 130. AMERICAS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 131. AMERICAS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2024 (USD MILLION)
  • TABLE 132. AMERICAS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2025-2032 (USD MILLION)
  • TABLE 133. AMERICAS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2024 (USD MILLION)
  • TABLE 134. AMERICAS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2025-2032 (USD MILLION)
  • TABLE 135. AMERICAS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 136. AMERICAS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 137. AMERICAS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 138. AMERICAS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 139. AMERICAS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 140. AMERICAS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. NORTH AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 144. NORTH AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2024 (USD MILLION)
  • TABLE 146. NORTH AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2025-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2024 (USD MILLION)
  • TABLE 148. NORTH AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2025-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 150. NORTH AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 152. NORTH AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 154. NORTH AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. LATIN AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 158. LATIN AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2024 (USD MILLION)
  • TABLE 160. LATIN AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2025-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2024 (USD MILLION)
  • TABLE 162. LATIN AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2025-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 164. LATIN AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 166. LATIN AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 168. LATIN AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2024 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2025-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2024 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2025-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 183. EUROPE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. EUROPE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. EUROPE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 186. EUROPE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 187. EUROPE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2024 (USD MILLION)
  • TABLE 188. EUROPE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2025-2032 (USD MILLION)
  • TABLE 189. EUROPE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2024 (USD MILLION)
  • TABLE 190. EUROPE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2025-2032 (USD MILLION)
  • TABLE 191. EUROPE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 192. EUROPE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 193. EUROPE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 194. EUROPE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 195. EUROPE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 197. MIDDLE EAST INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. MIDDLE EAST INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. MIDDLE EAST INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 200. MIDDLE EAST INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2024 (USD MILLION)
  • TABLE 202. MIDDLE EAST INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2025-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2024 (USD MILLION)
  • TABLE 204. MIDDLE EAST INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2025-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 206. MIDDLE EAST INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 208. MIDDLE EAST INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 210. MIDDLE EAST INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 211. AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 214. AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 215. AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2024 (USD MILLION)
  • TABLE 216. AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2025-2032 (USD MILLION)
  • TABLE 217. AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2024 (USD MILLION)
  • TABLE 218. AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2025-2032 (USD MILLION)
  • TABLE 219. AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 220. AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 221. AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 222. AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 223. AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 224. AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 225. ASIA-PACIFIC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. ASIA-PACIFIC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. ASIA-PACIFIC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 228. ASIA-PACIFIC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 229. ASIA-PACIFIC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2024 (USD MILLION)
  • TABLE 230. ASIA-PACIFIC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2025-2032 (USD MILLION)
  • TABLE 231. ASIA-PACIFIC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2024 (USD MILLION)
  • TABLE 232. ASIA-PACIFIC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2025-2032 (USD MILLION)
  • TABLE 233. ASIA-PACIFIC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 234. ASIA-PACIFIC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 236. ASIA-PACIFIC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 241. ASEAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. ASEAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. ASEAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 244. ASEAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 245. ASEAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2024 (USD MILLION)
  • TABLE 246. ASEAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2025-2032 (USD MILLION)
  • TABLE 247. ASEAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2024 (USD MILLION)
  • TABLE 248. ASEAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2025-2032 (USD MILLION)
  • TABLE 249. ASEAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 250. ASEAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 251. ASEAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 252. ASEAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 253. ASEAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 254. ASEAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 255. GCC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 256. GCC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 257. GCC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 258. GCC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 259. GCC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2024 (USD MILLION)
  • TABLE 260. GCC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2025-2032 (USD MILLION)
  • TABLE 261. GCC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2024 (USD MILLION)
  • TABLE 262. GCC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2025-2032 (USD MILLION)
  • TABLE 263. GCC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 264. GCC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 265. GCC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 266. GCC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 267. GCC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 268. GCC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPEAN UNION INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPEAN UNION INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPEAN UNION INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPEAN UNION INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPEAN UNION INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPEAN UNION INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPEAN UNION INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPEAN UNION INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPEAN UNION INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPEAN UNION INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPEAN UNION IN